AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: Analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements
Authors: Pei, J Akatsuka, Y Anasetti, C Lin, MT Petersdorf, EW Hansen, JA Martin, PJ
Citation: J. Pei et al., Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: Analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements, BIOL BLOOD, 7(7), 2001, pp. 378-383
Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation
Authors: Deeg, HJ Amylon, MD Harris, RE Collins, R Beatty, PG Feig, S Ramsay, N Territo, M Khan, SP Pamphilon, D Leis, JF Burdach, S Anasetti, C Hackman, R Storer, B Mueller, B
Citation: Hj. Deeg et al., Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation, BIOL BLOOD, 7(4), 2001, pp. 208-215
Trends in transplantation of hematopoietic stem cells from unrelated donors
Authors: Anasetti, C Petersdorf, EW Martin, PJ Woolfrey, A Hansen, JA
Citation: C. Anasetti et al., Trends in transplantation of hematopoietic stem cells from unrelated donors, CURR OPIN H, 8(6), 2001, pp. 337-341
Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients
Authors: Zerr, DM Gooley, TA Yeung, L Huang, ML Carpenter, P Wade, JC Corey, L Anasetti, C
Citation: Dm. Zerr et al., Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients, CLIN INF D, 33(6), 2001, pp. 763-771
Genomics of unrelated-donor hematopoietic cell transplantation
Authors: Petersdorf, E Anasetti, C Martin, PJ Woolfrey, A Smith, A Mickelson, E Malkki, M Lin, MT Hansen, JA
Citation: E. Petersdorf et al., Genomics of unrelated-donor hematopoietic cell transplantation, CURR OP IM, 13(5), 2001, pp. 582-589
Hematopoietic stern-cell transplantation for treatment-related leukemia ormyelodysplasia
Authors: Witherspoon, RP Deeg, HJ Storer, B Anasetti, C Storb, R Appelbaum, FR
Citation: Rp. Witherspoon et al., Hematopoietic stern-cell transplantation for treatment-related leukemia ormyelodysplasia, J CL ONCOL, 19(8), 2001, pp. 2134-2141
Advances in transplantation tolerance
Authors: Yu, XZ Carpenter, P Anasetti, C
Citation: Xz. Yu et al., Advances in transplantation tolerance, LANCET, 357(9272), 2001, pp. 1959-1963
Anti-CD3 epsilon F(ab ')(2) prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens
Authors: Yu, XZ Bidwell, SJ Martin, PJ Anasetti, C
Citation: Xz. Yu et al., Anti-CD3 epsilon F(ab ')(2) prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens, J IMMUNOL, 166(9), 2001, pp. 5835-5839
The biological significance of HLA-DP gene variation in haematopoietic cell transplantation
Authors: Petersdorf, EW Gooley, T Malkki, M Anasetti, C Martin, P Woolfrey, A Smith, A Mickelson, E Hansen, JA
Citation: Ew. Petersdorf et al., The biological significance of HLA-DP gene variation in haematopoietic cell transplantation, BR J HAEM, 112(4), 2001, pp. 988-994
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia
Authors: Jurado, M Deeg, HJ Gooley, T Anasetti, C Chauncey, T Flowers, MED Myerson, D Storb, R Appelbaum, FR
Citation: M. Jurado et al., Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia, BR J HAEM, 112(2), 2001, pp. 392-396
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
Authors: Kollman, C Howe, CWS Anasetti, C Antin, JH Davies, SM Filipovich, AH Hegland, J Kamani, N Kernan, NA King, R Ratanatharathorn, V Weisdorf, D Confer, DL
Citation: C. Kollman et al., Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age, BLOOD, 98(7), 2001, pp. 2043-2051
The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells
Authors: Ohishi, K Varnum-Finney, B Serda, RE Anasetti, C Bernstein, ID
Citation: K. Ohishi et al., The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells, BLOOD, 98(5), 2001, pp. 1402-1407
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial
Authors: Kansu, E Gooley, T Flowers, MED Anasetti, C Deeg, HJ Nash, RA Sanders, JE Witherspoon, RP Appelbaum, FR Storb, R Martin, PJ
Citation: E. Kansu et al., Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial, BLOOD, 98(13), 2001, pp. 3868-3870
The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase
Authors: Lee, SJ Klein, JP Anasetti, C Antin, JH Loberiza, FR Bowell, BJ LeMaistre, CF Litzow, MR Marks, D Waller, EK Matlack, M Giralt, S Horowitz, MM
Citation: Sj. Lee et al., The effect of pretransplant interferon therapy on the outcome of unrelateddonor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase, BLOOD, 98(12), 2001, pp. 3205-3211
Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factorsdetermining outcome
Authors: Cornelissen, JJ Carston, M Kollman, C King, R Dekker, AW Lowenberg, B Anasetti, C
Citation: Jj. Cornelissen et al., Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factorsdetermining outcome, BLOOD, 97(6), 2001, pp. 1572-1577
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
Authors: Carnevale-Schianca, F Martin, P Sullivan, K Flowers, M Gooley, T Anasetti, C Deeg, J Furlong, T McSweeney, P Storb, R Nash, RA
Citation: F. Carnevale-schianca et al., Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease, BIOL BLOOD, 6(6), 2000, pp. 613-620
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation
Authors: Flowers, MED Leisenring, W Beach, K Riddell, S Radich, JP Higano, CS Rowley, SD Chauncey, TR Bensinger, WI Sanders, JE Anasetti, C Storb, R Wade, J Appelbaum, FR Martin, PJ
Citation: Med. Flowers et al., Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation, BIOL BLOOD, 6(3A), 2000, pp. 321-326
Second allogeneic transplantation after failure of first autologous transplantation
Authors: Radich, JP Gooley, T Sanders, JE Anasetti, C Chauncey, T Appelbaum, FR
Citation: Jp. Radich et al., Second allogeneic transplantation after failure of first autologous transplantation, BIOL BLOOD, 6(3), 2000, pp. 272-279
Marrow transplants from unrelated donors as treatment for acute leukemia
Authors: Sierra, J Bjerke, J Hansen, J Martin, P Petersdorf, E Woolfrey, A Anasetti, C
Citation: J. Sierra et al., Marrow transplants from unrelated donors as treatment for acute leukemia, LEUK LYMPH, 39(5-6), 2000, pp. 495-507
Improving availability and safety of unrelated donor transplants
Authors: Anasetti, C Petersdorf, EW Martin, PJ Woolfrey, A Hansen, JA
Citation: C. Anasetti et al., Improving availability and safety of unrelated donor transplants, CURR OPIN O, 12(2), 2000, pp. 121-126
Transplantation of hematopoietic stem cells from alternate donors in acutemyelogenous leukemia
Authors: Anasetti, C
Citation: C. Anasetti, Transplantation of hematopoietic stem cells from alternate donors in acutemyelogenous leukemia, LEUKEMIA, 14(3), 2000, pp. 502-504
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acutegraft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities
Authors: Furlong, T Storb, R Anasetti, C Appelbaum, FR Deeg, HJ Doney, K Martin, P Sullivan, K Witherspoon, R Nash, RA
Citation: T. Furlong et al., Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acutegraft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities, BONE MAR TR, 26(9), 2000, pp. 985-991
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience
Authors: Sierra, J Storer, B Hansen, JA Martin, PJ Petersdorf, EW Woolfrey, A Matthews, D Sanders, JE Storb, R Appelbaum, FR Anasetti, C
Citation: J. Sierra et al., Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience, BONE MAR TR, 26(4), 2000, pp. 397-404
HLA matching in hematopoietic cell transplantation
Authors: Mickelson, EM Petersdorf, E Anasetti, C Martin, P Woolfrey, A Hansen, JA
Citation: Em. Mickelson et al., HLA matching in hematopoietic cell transplantation, HUMAN IMMUN, 61(2), 2000, pp. 92-100
Impact of HLA matching on hematopoietic cell transplants from unrelated donors
Authors: Hansen, JA Petersdorf, E Martin, PJ Woolfry, A Anasetti, C
Citation: Ja. Hansen et al., Impact of HLA matching on hematopoietic cell transplants from unrelated donors, VOX SANGUIN, 78, 2000, pp. 269-271
Risultati: 1-25 | 26-44